Given the specificity and efficacy of our agents with two-mannose moieties for CD206+ macrophages in wound healing, glioma, and stroke, we envision that our imaging agents could provide a valuable tool to noninvasively image and track healing and disease evolution, and to monitor macrophage-targeted therapeutic effects in experimental studies and in patients. Here, MRC1 is linked to glioma.